In vitro potency of various polymyxin B components.
作者信息
Tam Vincent H, Cao Henry, Ledesma Kimberly R, Hu Ming
出版信息
Antimicrob Agents Chemother. 2011 Sep;55(9):4490-1. doi: 10.1128/AAC.00119-11. Epub 2011 Jun 27.
Abstract
摘要
相似文献
1
In vitro potency of various polymyxin B components.
Antimicrob Agents Chemother. 2011 Sep;55(9):4490-1. doi: 10.1128/AAC.00119-11. Epub 2011 Jun 27.
2
Microbiological Assessment of Polymyxin B Components Tested Alone and in Combination.
Antimicrob Agents Chemother. 2015 Dec;59(12):7823-5. doi: 10.1128/AAC.01021-15. Epub 2015 Sep 21.
3
Paradoxical Effect of Polymyxin B: High Drug Exposure Amplifies Resistance in Acinetobacter baumannii.
Antimicrob Agents Chemother. 2016 Jun 20;60(7):3913-20. doi: 10.1128/AAC.02831-15. Print 2016 Jul.
4
In vitro evaluation of the antimicrobial activity of meropenem in combination with polymyxin B and gatifloxacin against Pseudomonas aeruginosa and Acinetobacter baumannii.
J Chemother. 2008 Apr;20(2):180-5. doi: 10.1179/joc.2008.20.2.180.
5
In vitro double and triple bactericidal activities of doripenem, polymyxin B, and rifampin against multidrug-resistant Acinetobacter baumannii, Pseudomonas aeruginosa, Klebsiella pneumoniae, and Escherichia coli.
Antimicrob Agents Chemother. 2010 Jun;54(6):2732-4. doi: 10.1128/AAC.01768-09. Epub 2010 Apr 5.
6
From Breast Cancer to Antimicrobial: Combating Extremely Resistant Gram-Negative "Superbugs" Using Novel Combinations of Polymyxin B with Selective Estrogen Receptor Modulators.
Microb Drug Resist. 2017 Jul;23(5):640-650. doi: 10.1089/mdr.2016.0196. Epub 2016 Dec 9.
7
Comparison of antibacterial activities of polymyxin B and colistin against multidrug resistant Gram negative bacteria.
Infect Dis (Lond). 2019 Sep;51(9):676-682. doi: 10.1080/23744235.2019.1640386. Epub 2019 Jul 12.
8
Synergistic combinations of polymyxins.
Int J Antimicrob Agents. 2016 Dec;48(6):607-613. doi: 10.1016/j.ijantimicag.2016.09.014. Epub 2016 Oct 24.
9
In vitro evaluation of ciclopirox as an adjuvant for polymyxin B against gram-negative bacteria.
J Antibiot (Tokyo). 2015 Jun;68(6):395-8. doi: 10.1038/ja.2014.164. Epub 2015 Jan 14.
10
Mutant prevention concentrations of colistin for Acinetobacter baumannii, Pseudomonas aeruginosa and Klebsiella pneumoniae clinical isolates.
J Antimicrob Chemother. 2014 Jan;69(1):275-7. doi: 10.1093/jac/dkt315. Epub 2013 Aug 29.
引用本文的文献
1
Pharmacodynamic Profile of EVER206, a Novel Polymyxin Antimicrobial, against Gram-Negative Bacteria in the Murine Thigh Infection Model.
Antimicrob Agents Chemother. 2023 May 17;67(5):e0173822. doi: 10.1128/aac.01738-22. Epub 2023 Apr 6.
2
Individual Components of Polymyxin B Modeled via Population Pharmacokinetics to Design Humanized Dosage Regimens for a Bloodstream and Lung Infection Model in Immune-Competent Mice.
Antimicrob Agents Chemother. 2023 May 17;67(5):e0019723. doi: 10.1128/aac.00197-23. Epub 2023 Apr 6.
3
Synthesis and Evaluation of Polymyxins Bearing Reductively Labile Disulfide-Linked Lipids.
J Med Chem. 2022 Dec 8;65(23):15878-15892. doi: 10.1021/acs.jmedchem.2c01528. Epub 2022 Nov 18.
4
Population Pharmacokinetics of Polymyxin B in Obese Patients for Resistant Gram-Negative Infections.
Front Pharmacol. 2021 Nov 22;12:754844. doi: 10.3389/fphar.2021.754844. eCollection 2021.
5
Comparing the Population Pharmacokinetics of and Acute Kidney Injury Due to Polymyxin B in Chinese Patients with or without Renal Insufficiency.
Antimicrob Agents Chemother. 2021 Jan 20;65(2). doi: 10.1128/AAC.01900-20.
6
Population Pharmacokinetics and Limited Sampling Strategy for Therapeutic Drug Monitoring of Polymyxin B in Chinese Patients With Multidrug-Resistant Gram-Negative Bacterial Infections.
Front Pharmacol. 2020 Jun 5;11:829. doi: 10.3389/fphar.2020.00829. eCollection 2020.
7
Direct modifications of the cyclic peptide Polymyxin B leading to analogues with enhanced in vitro antibacterial activity.
Bioorg Med Chem Lett. 2020 Jun 1;30(11):127163. doi: 10.1016/j.bmcl.2020.127163. Epub 2020 Mar 30.
8
Antimicrobial Susceptibility Testing for Polymyxins: Challenges, Issues, and Recommendations.
J Clin Microbiol. 2019 Mar 28;57(4). doi: 10.1128/JCM.01390-18. Print 2019 Apr.
9
A Rapid and Semi-Quantitative Gold Nanoparticles Based Strip Sensor for Polymyxin B Sulfate Residues.
Nanomaterials (Basel). 2018 Mar 5;8(3):144. doi: 10.3390/nano8030144.
10
Resurgence of Polymyxin B for MDR/XDR Gram-Negative Infections: An Overview of Current Evidence.
Crit Care Res Pract. 2017;2017:3635609. doi: 10.1155/2017/3635609. Epub 2017 Jul 6.
本文引用的文献
1
Prevalence, resistance mechanisms, and susceptibility of multidrug-resistant bloodstream isolates of Pseudomonas aeruginosa.
Antimicrob Agents Chemother. 2010 Mar;54(3):1160-4. doi: 10.1128/AAC.01446-09. Epub 2010 Jan 19.
2
Variability of polymyxin B major components in commercial formulations.
Int J Antimicrob Agents. 2010 Mar;35(3):308-10. doi: 10.1016/j.ijantimicag.2009.11.005. Epub 2009 Dec 31.
3
Contribution of OmpK36 to carbapenem susceptibility in KPC-producing Klebsiella pneumoniae.
J Med Microbiol. 2009 Oct;58(Pt 10):1303-1308. doi: 10.1099/jmm.0.012575-0. Epub 2009 Jun 25.
4
Decreased susceptibility to polymyxin B during treatment for carbapenem-resistant Klebsiella pneumoniae infection.
J Clin Microbiol. 2009 May;47(5):1611-2. doi: 10.1128/JCM.02466-08. Epub 2009 Mar 4.
5
Comment on: Development and validation of a reversed-phase high-performance liquid chromatography assay for polymyxin B in human plasma.
J Antimicrob Chemother. 2009 Mar;63(3):627-8; author reply 628-9. doi: 10.1093/jac/dkn483. Epub 2008 Nov 19.
6
Polymyxin B: a new strategy for multidrug-resistant Gram-negative organisms.
Expert Opin Investig Drugs. 2008 May;17(5):661-8. doi: 10.1517/13543784.17.5.661.
7
Multicity outbreak of carbapenem-resistant Acinetobacter baumannii isolates producing the carbapenemase OXA-40.
Antimicrob Agents Chemother. 2006 Sep;50(9):2941-5. doi: 10.1128/AAC.00116-06.
8
Citywide emergence of Pseudomonas aeruginosa strains with reduced susceptibility to polymyxin B.
J Antimicrob Chemother. 2005 Jun;55(6):954-7. doi: 10.1093/jac/dki153. Epub 2005 May 9.
9
Isolation and structural characterization of polymyxin B components.
J Chromatogr A. 2001 Apr 6;912(2):369-73. doi: 10.1016/s0021-9673(01)00585-4.
Zotero 插件